Schroeder Theodore R 4
4 · Nabriva Therapeutics plc · Filed Jan 4, 2023
Insider Transaction Report
Form 4
Schroeder Theodore R
Chief Executive Officer)
Transactions
- Tax Payment
Ordinary Shares
2022-12-31$1.89/sh−5$9→ 12,431 total
Footnotes (1)
- [F1]These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.